FR2388563B1 - - Google Patents

Info

Publication number
FR2388563B1
FR2388563B1 FR7713009A FR7713009A FR2388563B1 FR 2388563 B1 FR2388563 B1 FR 2388563B1 FR 7713009 A FR7713009 A FR 7713009A FR 7713009 A FR7713009 A FR 7713009A FR 2388563 B1 FR2388563 B1 FR 2388563B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7713009A
Other versions
FR2388563A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7713009A priority Critical patent/FR2388563A1/fr
Priority to BE187182A priority patent/BE866464A/fr
Priority to ES469225A priority patent/ES469225A1/es
Priority to DE19782818922 priority patent/DE2818922A1/de
Priority to CA302,203A priority patent/CA1103155A/fr
Priority to CH469078A priority patent/CH630806A5/fr
Priority to GB16933/78A priority patent/GB1603340A/en
Priority to NL7804660A priority patent/NL7804660A/xx
Priority to IT49126/78A priority patent/IT1156717B/it
Priority to JP5262378A priority patent/JPS53136516A/ja
Publication of FR2388563A1 publication Critical patent/FR2388563A1/fr
Application granted granted Critical
Publication of FR2388563B1 publication Critical patent/FR2388563B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7713009A 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires Granted FR2388563A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
ES469225A ES469225A1 (es) 1977-04-29 1978-04-27 Procedimiento para potenciar la accion de las vacunas.
BE187182A BE866464A (fr) 1977-04-29 1978-04-27 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires.
CA302,203A CA1103155A (fr) 1977-04-29 1978-04-28 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
DE19782818922 DE2818922A1 (de) 1977-04-29 1978-04-28 Verbesserte impfstoffe mit gehalt an kapselpolysacchariden
CH469078A CH630806A5 (en) 1977-04-29 1978-04-28 Method for preparing improved vaccines
GB16933/78A GB1603340A (en) 1977-04-29 1978-04-28 Potentiated acellular vaccines
NL7804660A NL7804660A (nl) 1977-04-29 1978-04-28 Verbeterde vaccins.
IT49126/78A IT1156717B (it) 1977-04-29 1978-04-28 Procedimento per ottenere vaccini acellulari potenziati
JP5262378A JPS53136516A (en) 1977-04-29 1978-05-01 Cell extracted vaccine having polysacchride capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Publications (2)

Publication Number Publication Date
FR2388563A1 FR2388563A1 (fr) 1978-11-24
FR2388563B1 true FR2388563B1 (fr) 1981-01-09

Family

ID=9190107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713009A Granted FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Country Status (10)

Country Link
JP (1) JPS53136516A (fr)
BE (1) BE866464A (fr)
CA (1) CA1103155A (fr)
CH (1) CH630806A5 (fr)
DE (1) DE2818922A1 (fr)
ES (1) ES469225A1 (fr)
FR (1) FR2388563A1 (fr)
GB (1) GB1603340A (fr)
IT (1) IT1156717B (fr)
NL (1) NL7804660A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (fr) * 1977-11-28 1981-12-29 Dennis J. Carlo Vaccin contre les pneumocoques
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
FR2495939B1 (fr) * 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
GB8906795D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Method of preparing vaccines
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
JPH0651347U (ja) * 1992-12-21 1994-07-12 有限会社河上建築事務所 軒樋の枯葉止め
FR2703252B1 (fr) 1993-03-31 1996-09-06 Fernand Narbey Torossian Complexe immunomodulateur anti SIDA.
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
PT897427E (pt) * 1996-02-14 2005-01-31 Merck & Co Inc Processo de precipitacao de polissacarideos
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

Also Published As

Publication number Publication date
DE2818922A1 (de) 1978-11-09
GB1603340A (en) 1981-11-25
FR2388563A1 (fr) 1978-11-24
CA1103155A (fr) 1981-06-16
ES469225A1 (es) 1978-11-16
CH630806A5 (en) 1982-07-15
BE866464A (fr) 1978-10-27
JPS53136516A (en) 1978-11-29
NL7804660A (nl) 1978-10-31
IT7849126A0 (it) 1978-04-28
IT1156717B (it) 1987-02-04

Similar Documents

Publication Publication Date Title
CH642799GA3 (fr)
DE2849967C2 (fr)
FR2388563B1 (fr)
DE2843782C2 (fr)
FR2376809B1 (fr)
DE2740382C2 (fr)
FR2407000B1 (fr)
DE2744769C2 (fr)
AU3353778A (fr)
FR2377170B3 (fr)
AU495917B2 (fr)
AR210643A1 (fr)
FR2363890B3 (fr)
AU71461S (fr)
BG23438A1 (fr)
BG25808A1 (fr)
BG25820A1 (fr)
BG25822A1 (fr)
BG25823A1 (fr)
BG25851A1 (fr)
BG25824A1 (fr)
BG25815A1 (fr)
BG25825A1 (fr)
BG25813A1 (fr)
BG25812A1 (fr)

Legal Events

Date Code Title Description
TP Transmission of property